|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 471/08 | (2006.01) |
| A61K 31/439 | (2006.01) | ||
| A61P 31/04 | (2006.01) |
| (11) | Number of the document | 2834239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13715426.6 |
| Date of filing the European patent application | 2013-04-02 | |
| (97) | Date of publication of the European application | 2015-02-11 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-27 |
| (46) | Date of publication of the claims translation | 2018-03-26 |
| (86) | Number | PCT/GB2013/050869 |
| Date | 2013-04-02 |
| (87) | Number | WO 2013/150296 |
| Date | 2013-10-10 |
| (30) | Number | Date | Country code |
| 201261618993 P | 2012-04-02 | US |
| (72) |
MCGUIRE, Helen, US
BIST, Shanta, US
BIFULCO, Neil, US
ZHAO, Liang, US
WU, Ye, US
HUYNH, Hoan, US
XIONG, Hui, US
COMITA-PREVOIR, Janelle, US
DUSSAULT, Daemian, US
GENG, Bolin, US
CHEN, Brendan, US
DURAND-REVILLE, Thomas, US
GULER, Satenig, US
|
| (73) |
Entasis Therapeutics Limited,
2 Kingdom Street, London W2 6BD,
GB
|
| (74) |
Stanislava TELEIŠIENĖ,
UAB "Brainera", Taikos 235-17, LT-05213 Vilnius,
LT
|
| (54) | Heterobicikliniai junginiai kaip beta-laktamazės inhibitoriai |
| HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2026-03-18 | 14 | 289.00 EUR |
| 2027-04-02 |